Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

DexCom, Inc. DXCM NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
82/100
7/7 Pass
SharesGrow Intrinsic Value
$98.26
+59.7%
Analyst Price Target
$85.82
+39.5%

Balance sheet is a point-in-time snapshot. TTM shows the most recent available quarter.

Metric Latest Quarter (2025-12)
Total Assets $6.34B
Total Liabilities $3.59B
Total Debt $1.39B
Cash & Investments $2B
Total Stockholders Equity $2.75B

People Also View

ABT
ABT
Abbott Laboratories
$101.50
+0.45%
 MDT
MDT
Medtronic plc
$87.10
-1.16%
 BSX
BSX
Boston Scientific Corporation
$64.61
+1.24%
 EW
EW
Edwards Lifesciences Corporation
$78.20
-0.01%
 ZBH
ZBH
Zimmer Biomet Holdings, Inc.
$94.20
-2.40%
 PODD
PODD
Insulet Corporation
$202.50
+0.50%
 PEN
PEN
Penumbra, Inc.
$332.42
+0.08%
 SWAV
SWAV
ShockWave Medical, Inc.
$334.75
-0.02%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message